Buy Ultane 250 mL/250mL Sevoflurane

Ultane 250 mL/250mL is a liquid inhalation anesthetic containing sevoflurane. It is commonly used for induction and maintenance of general anesthesia in surgical procedures. This product is manufactured by AbbVie Inc. in the USA.

Strength

250 mL/250mL

Pack Size

250 mL in 1 BOTTLE, PLASTIC (0074-4456-51)

Manufacturer / TM Owner

AbbVie Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Sevoflurane, the active ingredient in Ultane, is primarily used as an inhalation anesthetic. It is often employed to induce and maintain general anesthesia during surgical procedures. The liquid form is designed for respiratory administration, providing controlled and precise dosing for medical professionals.

Side Effects

Ultane 250 mL/250mL is designed to induce a state of general anesthesia, which typically results in unconsciousness and loss of pain sensation. The effects are intended to be temporary and reversible, allowing patients to regain consciousness after the procedure. Common side effects may include respiratory depression and changes in blood pressure.

Precautions & Warnings

Ultane should be handled with care, as it is intended for use by trained medical professionals only. Proper ventilation and safety measures should be in place during administration. Patients with a history of malignant hyperthermia or other anesthesia-related complications should be monitored closely.

Avoid Interactions

Sevoflurane may interact with other anesthetics, muscle relaxants, and certain medications that affect the central nervous system. It is important to inform healthcare providers about all medications being taken to avoid potential interactions. Alcohol and other sedatives should be avoided before and after administration.

References

Frequently Asked Questions

Ultane is used as an inhalation anesthetic to induce and maintain general anesthesia during surgical procedures.

Ultane is administered via inhalation, typically using specialized anesthesia equipment.

Common side effects may include respiratory depression and changes in blood pressure.

Ultane may interact with other anesthetics and medications that affect the central nervous system. Consult a healthcare provider for specific guidance.

Ultane should be used with caution in patients with a history of malignant hyperthermia or other anesthesia-related complications.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.